• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

扩张的 DNA 和 RNA 三核苷酸重复序列在 1 型肌强直性营养不良中选择其自身的多靶点、序列选择性抑制剂。

Expanded DNA and RNA Trinucleotide Repeats in Myotonic Dystrophy Type 1 Select Their Own Multitarget, Sequence-Selective Inhibitors.

机构信息

Department of Chemistry, University of Illinois at Urbana-Champaign, Urbana, Illinois 61801, United States.

National Magnetics Resonance Facility at Madison, Biochemistry Department, University of Wisconsin-Madison, Madison, Wisconsin 53706, United States.

出版信息

Biochemistry. 2020 Sep 22;59(37):3463-3472. doi: 10.1021/acs.biochem.0c00472. Epub 2020 Sep 10.

DOI:10.1021/acs.biochem.0c00472
PMID:32856901
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7793557/
Abstract

There are few methods available for the rapid discovery of multitarget drugs. Herein, we describe the template-assisted, target-guided discovery of small molecules that recognize d(CTG) in the expanded d(CTG·CAG) sequence and its r(CUG) transcript that cause myotonic dystrophy type 1. A positive cross-selection was performed using a small library of 30 monomeric alkyne- and azide-containing ligands capable of producing >5000 possible di- and trimeric click products. The monomers were incubated with d(CTG) or r(CUG) under physiological conditions, and both sequences showed selectivity in the proximity-accelerated azide-alkyne [3+2] cycloaddition click reaction. The limited number of click products formed in both selections and the even smaller number of common products suggests that this method is a useful tool for the discovery of single-target and multitarget lead therapeutic agents.

摘要

目前,快速发现多靶标药物的方法较少。在此,我们描述了一种模板辅助、基于靶标的小分子发现方法,这些小分子可以识别导致 1 型肌强直性营养不良的扩展 d(CTG·CAG)序列及其 r(CUG)转录物中的 d(CTG)。使用能够产生>5000 种可能的二聚体和三聚体点击产物的 30 个单体炔基和叠氮化物小分子文库进行了正交叉选择。将单体在生理条件下与 d(CTG)或 r(CUG)孵育,这两个序列都表现出在邻近加速的叠氮-炔烃[3+2]环加成点击反应中的选择性。在两种选择中形成的点击产物数量有限,并且共同产物的数量更少,这表明该方法是发现单靶标和多靶标治疗剂的有用工具。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94c1/7793557/ebe240c5646f/nihms-1654201-f0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94c1/7793557/ea4886c43082/nihms-1654201-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94c1/7793557/e32aecf9d6a7/nihms-1654201-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94c1/7793557/25725c963d98/nihms-1654201-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94c1/7793557/d5c36f936659/nihms-1654201-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94c1/7793557/8fa41e8ebf95/nihms-1654201-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94c1/7793557/d46ed304f4a5/nihms-1654201-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94c1/7793557/1ff0a1a22aa0/nihms-1654201-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94c1/7793557/cd28f2d819c8/nihms-1654201-f0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94c1/7793557/ebe240c5646f/nihms-1654201-f0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94c1/7793557/ea4886c43082/nihms-1654201-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94c1/7793557/e32aecf9d6a7/nihms-1654201-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94c1/7793557/25725c963d98/nihms-1654201-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94c1/7793557/d5c36f936659/nihms-1654201-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94c1/7793557/8fa41e8ebf95/nihms-1654201-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94c1/7793557/d46ed304f4a5/nihms-1654201-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94c1/7793557/1ff0a1a22aa0/nihms-1654201-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94c1/7793557/cd28f2d819c8/nihms-1654201-f0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94c1/7793557/ebe240c5646f/nihms-1654201-f0009.jpg

相似文献

1
Expanded DNA and RNA Trinucleotide Repeats in Myotonic Dystrophy Type 1 Select Their Own Multitarget, Sequence-Selective Inhibitors.扩张的 DNA 和 RNA 三核苷酸重复序列在 1 型肌强直性营养不良中选择其自身的多靶点、序列选择性抑制剂。
Biochemistry. 2020 Sep 22;59(37):3463-3472. doi: 10.1021/acs.biochem.0c00472. Epub 2020 Sep 10.
2
Rationally designed small molecules that target both the DNA and RNA causing myotonic dystrophy type 1.针对导致 1 型肌强直性营养不良的 DNA 和 RNA 的合理设计的小分子。
J Am Chem Soc. 2015 Nov 11;137(44):14180-9. doi: 10.1021/jacs.5b09266. Epub 2015 Nov 3.
3
A CTG repeat-selective chemical screen identifies microtubule inhibitors as selective modulators of toxic CUG RNA levels.一种 CTG 重复序列选择性化学筛选方法,可识别微管抑制剂作为毒性 CUG RNA 水平的选择性调节剂。
Proc Natl Acad Sci U S A. 2019 Oct 15;116(42):20991-21000. doi: 10.1073/pnas.1901893116. Epub 2019 Sep 30.
4
Novel proteins with binding specificity for DNA CTG repeats and RNA CUG repeats: implications for myotonic dystrophy.对DNA CTG重复序列和RNA CUG重复序列具有结合特异性的新型蛋白质:对强直性肌营养不良的意义。
Hum Mol Genet. 1996 Jan;5(1):115-21. doi: 10.1093/hmg/5.1.115.
5
A Selective Alkylating Agent for CTG Repeats in Myotonic Dystrophy Type 1.一种用于肌强直性营养不良 1 型的 CTG 重复的选择性烷化剂。
ACS Chem Biol. 2022 May 20;17(5):1103-1110. doi: 10.1021/acschembio.1c00949. Epub 2022 Apr 28.
6
In silico discovery of substituted pyrido[2,3-d]pyrimidines and pentamidine-like compounds with biological activity in myotonic dystrophy models.在计算机模拟中发现具有强直性肌营养不良模型生物活性的取代吡啶并[2,3-d]嘧啶和喷他脒类化合物。
PLoS One. 2017 Jun 5;12(6):e0178931. doi: 10.1371/journal.pone.0178931. eCollection 2017.
7
Precise small-molecule cleavage of an r(CUG) repeat expansion in a myotonic dystrophy mouse model.精准切割肌强直性营养不良小鼠模型中的 r(CUG)重复扩展的小分子。
Proc Natl Acad Sci U S A. 2019 Apr 16;116(16):7799-7804. doi: 10.1073/pnas.1901484116. Epub 2019 Mar 29.
8
A Small Molecule that Binds an RNA Repeat Expansion Stimulates Its Decay via the Exosome Complex.一种小分子与 RNA 重复扩展结合,通过外泌体复合物刺激其降解。
Cell Chem Biol. 2021 Jan 21;28(1):34-45.e6. doi: 10.1016/j.chembiol.2020.10.007. Epub 2020 Nov 5.
9
A Potent Inhibitor of Protein Sequestration by Expanded Triplet (CUG) Repeats that Shows Phenotypic Improvements in a Drosophila Model of Myotonic Dystrophy.一种由扩展三联体(CUG)重复序列介导的蛋白质隔离的强效抑制剂,在强直性肌营养不良果蝇模型中显示出表型改善。
ChemMedChem. 2016 Jul 5;11(13):1428-35. doi: 10.1002/cmdc.201600081. Epub 2016 Jun 1.
10
Identification of Plant-derived Alkaloids with Therapeutic Potential for Myotonic Dystrophy Type I.鉴定对Ⅰ型强直性肌营养不良具有治疗潜力的植物源生物碱。
J Biol Chem. 2016 Aug 12;291(33):17165-77. doi: 10.1074/jbc.M115.710616. Epub 2016 Jun 13.

引用本文的文献

1
Heterobifunctional small molecules to modulate RNA function.用于调节 RNA 功能的杂双功能小分子。
Trends Pharmacol Sci. 2024 May;45(5):449-463. doi: 10.1016/j.tips.2024.03.006. Epub 2024 Apr 18.
2
A couple of the first cousins born with hypotonia and maternal polyhydramnios.有几个表亲出生时患有肌张力减退和母亲羊水过多。
Clin Case Rep. 2024 Feb 7;12(2):e8503. doi: 10.1002/ccr3.8503. eCollection 2024 Feb.
3
Small molecule approaches to targeting RNA.靶向RNA的小分子方法。

本文引用的文献

1
Template-guided selection of RNA ligands using imine-based dynamic combinatorial chemistry.使用基于亚胺的动态组合化学进行 RNA 配体的模板指导选择。
Chem Commun (Camb). 2020 Mar 24;56(24):3555-3558. doi: 10.1039/d0cc00266f.
2
Kinetic Target-Guided Synthesis: Reaching the Age of Maturity.动力学靶向导向合成:走向成熟。
J Med Chem. 2020 Apr 23;63(8):3817-3833. doi: 10.1021/acs.jmedchem.9b01183. Epub 2019 Dec 24.
3
R-BIND: An Interactive Database for Exploring and Developing RNA-Targeted Chemical Probes.R-BIND:一个用于探索和开发 RNA 靶向化学探针的交互式数据库。
Nat Rev Chem. 2024 Feb;8(2):120-135. doi: 10.1038/s41570-023-00569-9. Epub 2024 Jan 26.
4
Selective and Reversible Ligand Assembly on the DNA and RNA Repeat Sequences in Myotonic Dystrophy.选择性和可逆性配体组装在肌强直性营养不良的 DNA 和 RNA 重复序列上。
Chembiochem. 2022 Sep 5;23(17):e202200260. doi: 10.1002/cbic.202200260. Epub 2022 Jul 19.
5
Versatile Target-Guided Screen for Discovering Bidirectional Transcription Inhibitors of a Trinucleotide Repeat Disease.用于发现三核苷酸重复疾病双向转录抑制剂的通用靶点导向筛选
ACS Med Chem Lett. 2021 May 21;12(6):935-940. doi: 10.1021/acsmedchemlett.1c00064. eCollection 2021 Jun 10.
6
Massively Parallel Optimization of the Linker Domain in Small Molecule Dimers Targeting a Toxic r(CUG) Repeat Expansion.针对有毒r(CUG)重复扩增的小分子二聚体中接头结构域的大规模平行优化
ACS Med Chem Lett. 2021 Mar 2;12(6):907-914. doi: 10.1021/acsmedchemlett.1c00027. eCollection 2021 Jun 10.
7
Affecting RNA biology genome-wide by binding small molecules and chemically induced proximity.通过结合小分子和化学诱导的邻近作用,影响全基因组的 RNA 生物学。
Curr Opin Chem Biol. 2021 Jun;62:119-129. doi: 10.1016/j.cbpa.2021.03.006. Epub 2021 Jun 9.
ACS Chem Biol. 2019 Dec 20;14(12):2691-2700. doi: 10.1021/acschembio.9b00631. Epub 2019 Oct 29.
4
Structure of an RNA helix with pyrimidine mismatches and cross-strand stacking.具有嘧啶错配和跨链堆积的RNA螺旋结构
Acta Crystallogr F Struct Biol Commun. 2019 Oct 1;75(Pt 10):652-656. doi: 10.1107/S2053230X19012172. Epub 2019 Sep 24.
5
Mitigating RNA Toxicity in Myotonic Dystrophy using Small Molecules.使用小分子减轻肌强直性营养不良的 RNA 毒性。
Int J Mol Sci. 2019 Aug 17;20(16):4017. doi: 10.3390/ijms20164017.
6
CRISPR/Cas Applications in Myotonic Dystrophy: Expanding Opportunities.CRISPR/Cas 技术在强直性肌营养不良症中的应用:拓展机遇
Int J Mol Sci. 2019 Jul 27;20(15):3689. doi: 10.3390/ijms20153689.
7
Development of novel macrocyclic small molecules that target CTG trinucleotide repeats.新型大环小分子靶向 CTG 三核苷酸重复序列的开发。
Bioorg Med Chem. 2019 Jul 1;27(13):2978-2984. doi: 10.1016/j.bmc.2019.05.022. Epub 2019 May 14.
8
Intrinsically cell-penetrating multivalent and multitargeting ligands for myotonic dystrophy type 1.肌强直性营养不良 1 型的内在穿透性多价和多靶点配体。
Proc Natl Acad Sci U S A. 2019 Apr 30;116(18):8709-8714. doi: 10.1073/pnas.1820827116. Epub 2019 Apr 11.
9
Fragment-Based Drug Discovery: Advancing Fragments in the Absence of Crystal Structures.基于片段的药物发现:在没有晶体结构的情况下推进片段。
Cell Chem Biol. 2019 Jan 17;26(1):9-15. doi: 10.1016/j.chembiol.2018.10.001. Epub 2018 Oct 25.
10
Therapeutic Genome Editing for Myotonic Dystrophy Type 1 Using CRISPR/Cas9.使用 CRISPR/Cas9 治疗 1 型肌强直性营养不良症的基因组编辑
Mol Ther. 2018 Nov 7;26(11):2617-2630. doi: 10.1016/j.ymthe.2018.09.003. Epub 2018 Sep 11.